There is so much healthcare data available today but not enough is being collected or used in an integrated manner that is interfaceable between the different…
In Conversation
The way health services are rendered to patients is evolving well, but patient-doctor interactions and relationships still tend to be quite traditional. The last year changed…
For me, Switzerland is one of the best places in Europe to start a business
At Roche, we are looking at how we can support this needed shift towards a digitalised healthcare system. Our focus is shifting more and more towards…
With a clear vision and the imposition of privatization [in the Arab world], many opportunities have emerged for foreign companies to participate in tenders and gain…
When we collaborate with any industry, we have to start by doing the painstaking work of understanding their needs and their language to create the bridge…
Technology will certainly continue to impact our industry, even though it will take time. The nature of our services requires a human touch, especially in the…
The consumer goods market, especially online, values three characteristics above all else. These are speed, transparency – having an immediate overview of everything that is available…
There are very few treatment options available to women and they, therefore, need and deserve new and more innovative treatment options
SFDA has been developing very fast over the past couple of years and our future is even more promising. We are improving our regulations and processes…
It is in our DNA to look for and assess opportunities. We assess around 500 potential product opportunities per year with the aim of in-licensing only…
There is no question that bispecific and multispecific antibodies represent novel modalities that enable unique modes of action and possibilities for therapeutic intervention
